| Q33932167 | Association of NQO1 and TNF polymorphisms with Parkinson's disease: A meta-analysis of 15 genetic association studies |
| Q33599444 | Association of TNF-alpha gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study |
| Q33907156 | Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain |
| Q64096099 | Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease |
| Q85110030 | Lack of association between IL-1β, TNF-α, and IL-10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort |
| Q39055955 | Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin. |
| Q27027973 | Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity |
| Q33353554 | Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? |
| Q29616300 | Neuroinflammation in Parkinson's disease: a target for neuroprotection? |
| Q37741285 | Pharmacological therapy in Parkinson's disease: focus on neuroprotection |
| Q36165760 | Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation |
| Q26796241 | Relevance of chronic stress and the two faces of microglia in Parkinson's disease |
| Q35510197 | Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. |
| Q21093232 | TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease |
| Q38105903 | The role of inflammation in sporadic and familial Parkinson's disease |
| Q28283160 | Vinpocetine as a potent antiinflammatory agent |
| Q57472025 | Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients |